STOCK TITAN

IDEXX’s Michael Lane exercises options for 863 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

IDEXX Laboratories (IDXX) Executive Vice President Michael Lane exercised options for 863 common shares on November 18, 2026: 483 at an exercise price of $206.94, 183 at $544.08 and 197 at $505.53. The three option tranches vested in one installment on February 14 of 2024, 2025 and 2026, respectively. Separately, 592 common shares were held by his spouse in an IRA; Lane disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Lane Michael
Role Executive Vice President
Type Security Shares Price Value
Exercise Incentive Stock Option (right-to-buy) F2 483 $0.00 $0.00
Exercise Incentive Stock Option (right-to-buy) F3 183 $0.00 $0.00
Exercise Incentive Stock Option (right-to-buy) F4 197 $0.00 $0.00
Exercise Common Stock 483 $206.94 $100K
Exercise Common Stock 183 $544.08 $100K
Exercise Common Stock 197 $505.53 $100K
Holding Common Stock F1 -- -- --
Holdings After Transaction: Incentive Stock Option (right-to-buy) — 0 options (Direct); Common Stock — 4,939 shares (Direct); Common Stock — 592 shares (Indirect, by spouse)
Holdings Before and After: Incentive Stock Option (right-to-buy), 863 to 0 options (Direct); Common Stock, 4,076 to 4,939 shares (Direct)
Footnotes (4)
  1. F1. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
  2. F2. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024
  3. F3. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.
  4. F4. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.
Options exercised 863 shares Across three option tranches on November 18, 2026.
Option exercise 483 shares at $206.94 per share The option tranche vested in one installment on February 14, 2024.
Option exercise 183 shares at $544.08 per share The option tranche vested in one installment on February 14, 2025.
Option exercise 197 shares at $505.53 per share The option tranche vested in one installment on February 14, 2026.
Spouse-held common shares 592 shares Held by Lane’s spouse in an IRA account; Lane disclaims beneficial ownership except to the extent of his pecuniary interest.
Incentive Stock Option technical
"Incentive Stock Option (right-to-buy)"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
IRA account financial
"Held by the reporting person’s spouse in an IRA account"
pecuniary interest financial
"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IDXX shares did Michael Lane acquire through option exercises, and at what prices?

Michael Lane acquired 863 common shares through option exercises on November 18, 2026, in three tranches: 483 at $206.94, 183 at $544.08 and 197 at $505.53.

When did Michael Lane’s IDXX options vest?

The options covering 483 shares vested in one installment on February 14, 2024; options covering 183 shares vested on February 14, 2025; and those covering 197 shares vested on February 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lane Michael

(Last)(First)(Middle)
ONE IDEXX DRIVE

(Street)
WESTBROOK MAINE 04092

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Executive Vice President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/18/2026M483A$206.944,559D
Common Stock11/18/2026M183A$544.084,742D
Common Stock11/18/2026M197A$505.534,939D
Common Stock592(1)Iby spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Option (right-to-buy)$206.9411/18/2026M483 (2)02/13/2029Common Stock483$00D
Incentive Stock Option (right-to-buy)$544.0811/18/2026M183 (3)02/13/2031Common Stock183$00D
Incentive Stock Option (right-to-buy)$505.5311/18/2026M197 (4)02/13/2032Common Stock197$00D
Explanation of Responses:
1. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
2. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024
3. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.
4. Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.
Remarks:
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading